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ABSTRACT

Kumchala Prasanthi. M.S., Department of Microbiology and Immunology, Wright State
University, 2012. MHC class I expression in murine fibroblast and keratinocyte cell lines
during the first twenty-four hours of Infection with Herpes Simplex Virus-1 (HSV-1).

The hypothesis of this study is: HSV-1 infection of murine fibroblasts and
keratinocytes inhibits expression of MHC class I molecules during first 24 hours of
infection. IFN-γ pretreatment of fibroblasts protected the cells from virus-induced
inhibition of MHC class I expression, but did not protect keratinocytes. Herpesviruses are
known for their ability to establish persistent infections. Herpesviruses exert many
different ways to suppress host defense mechanisms.

One such way is by down

regulating expression of the major histocompatibility complex I (MHC I) molecules in
infected cells. Epidermal cells such as keratinocytes are the major sites for herpes
simplex virus type 1 (HSV-1) replication both in active primary and recurring herpes
infection. In this study, murine keratinocyte cell lines (HEL-30 & PAM-212) were shown
to be refractory to IFN-γ induction of an MHC class I expression to HSV-1 infection,
while IFN-γ did induce MHC class I expression in murine fibroblast cell lines (L929 &
A2R1). In the current study, using Image J analyses of immunocytochemical data, MHC
class I expression decreased at 6, 12, and 24 hours after infection of L929 and A2R1
fibroblasts (p< 0.001) with HSV-1 infection. The effect of IFN- on expression of MHC
I molecules was evaluated in HSV-1-infected murine keratinocytes and fibroblasts at 24
hours after infection. In other studies, IFN- was found to protect the murine fibroblast
cell line, L929 from the cytopathic effect of HSV-1 but was unable to protect murine
iii

keratinocyte cell lines (HEL-30 and PAM-212) from HSV-1 induced cytopathic effects
(Frey et al., 2009). Immunofluorescent staining for expression of MHC class I molecules
in IFN- treated and HSV-1 infected cells was performed using immunocytochemistry
and flow cytometry. Only the fibroblast cell lines could be examined by both methods.
Significant increases (p < 0.001) in expression of MHC class I molecules were seen in
both HSV-1 infected fibroblast cell lines after treatment with IFN- using both
immunocytochemistry and flow cytometry.

Since keratinocytes grow in clusters,

immunocytochemistry was not used to evaluate their expression of the MHC class I
molecules in HSV-1-infected and IFN- treated cells. Keratinocytes could be gently
removed from the culture using cell stripper solution, and were then examined by flow
cytometry for expression of MHC class I molecules. In both keratinocyte cell lines,
significant decreases in expression levels of MHC class I molecules over baseline levels
(p<0.001) were observed after HSV-1 infection and IFN- treatment.
In the current study, HSV-1 infection of murine fibroblasts and keratinocytes
inhibited expression of MHC class I molecules during first 24 hours of infection. IFN-γ
pretreatment of fibroblasts protected them from virus-induced inhibition of MHC class I
expression, but did not protect keratinocytes. The refractoriness of keratinocytes to IFNγ might be due to the expression of suppressor of cytokine synthesis-1 (SOCS-1) during
HSV-1 infection as observed by the Frey et al., (2009).
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Introduction

Alpha herpes viruses constitute the largest subfamily of the Herpes viridae which
will cause infections to humans and animals. The human alpha herpes viruses, herpes
simplex viruses type 1 (HSV-1), type 2 (HSV-2) and varicella-zoster virus (VZV) are
antigenitically distinct.

HSV-1 can be diagnosed through oral blisters and HSV-2

through genital ulcers (Pena et al., 2010). Historically, HSV-1 was found infrequently in
genital HSV infections, but recent studies show an increase in prevalence up to 60%
(Marshall et al., 2001). HSV-1 also leads to infections like ocular herpes, which range
from mild to severe stromal keratitis symptoms. HSV-1 may also result in blindness,
encephalitis, aseptic meningitis and atypical pneumonia (Whitley, 2001).
HSV-1 is a double stranded DNA virus that causes both productive and latent
infections. Latent infection can persist in the body throughout the life of the host. HSV-1
hides from the immune system by residing latently in the cell bodies of nerves. When
activated, the virus will be transported to the skin from the nerves where they replicate
and cause sores (Norkin, 2010). The HSV virion (Figure 1A) is comprised of the viral
double-stranded DNA, an icosahedral capsid shell, a tegument layer containing numerous
viral proteins and a lipid membrane envelope studded with viral glycoproteins. The HSV
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genome (Figure 1B) is composed of long (L) and short (S) components with a unique
region (U) flanked by inverted repeat regions (Taylor et al., 2002).

Figure 1: HSV virion structure and genome organization. The HSV virion (A), the
major structural components of the virion can be seen in an EM photograph (right)
where the viral envelope is ruptured and folded back. The HSV genome (B) is
organized into two components, long (L) and short (S). Each component contains a
unique region (U) flanked by inverted repeat regions and are linked to generate a
total genome size of approximately 150,000 base pairs. (Adapted from Taylor et al.,
2002).
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HSV-1 utilizes glycoprotein-receptor complexes gB, gC, gD, gH, and gL during
host entry and these are essential for host cell entry (Figure 2A) (Shukla et al., 2001).
Initial contact and binding is made by the gC with the heparan sulfate (HS) proteoglycans
on host cell surface in case of fibroblasts (Lilly et al.,1998). HSV-1 attaches using
extracellular receptors in non-neuronal cells through filopodia-like membrane protrusions
and reaches the cell for internalization (Figure 2B) (Oh et al., 2010). Keratinocytes are
the major sites of HSV-1 replication in primary or recurring herpes infection
(Cunningham et al., 2006). In particular, infection of keratinocytes occurs through
endocytic processes (Figure 2B) (Nicola et al., 2005). Once fusion of the virus is
completed, the viral genome enters the nucleus through the nuclear pore complex (Shahin
et al., 2006). During subsequent lytic infection, the virus is able to move from the initial
site of infection through the underlying strata to reach the innervating neurons (Wharton
et al., 1995). Once virus traverses through neuron it establishes a latent state which is
maintained by CD8+ T cells and IFN-γ (Hendricks et al., 1992).
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Figure 2: Genomic distribution of HSV glycoproteins involved in viral entry and
cell-to-cell spread. A. Glycoprotein genes required for HSV-1 entry and spread.
HSV contains a 152-kb double-stranded linear DNA genome encoding over 80 viral
genes that are arranged as unique long (UL) and unique short (US) segments
flanked by inverted repeat sequences (boxes). The inverted repeats contain
sequences required for cleavage/packaging of the viral genome. B. Pathways of HSV
entry into cells. (I) penetration by viral envelope fusion at the plasma membrane
and (II) endocytosis (Adapted from Sarah et al., 2012).

The immune system plays a major role in protecting the body from infection. The
system is divided into two major branches: the innate immune system and the adaptive
immune system. Innate immune system is the first line of defense when the body is
exposed to invading microbes. Adaptive immune system is only found in vertebrates.
Assembly of antigen-binding molecules specific for structures of intracellular or
extracellular pathogens takes place in adaptive immune system (Rupert and Robert,
2004).
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Two types of cells present in the adaptive immune system are B cells and T cells.
B cells are involved in humoral immune response and carry antigen-specific B cell
receptors on their cell surface. In the presence of infection, B cells will be activated and
release antibodies that bind to the antigen. T cells recognize antigenic peptides presented
on the surface of host cells through major histocompatibility complex (MHC) molecules
(Rupert and Robert, 2004). There are two types of MHC molecules. MHC class I
molecules are found on all nucleated cell bodies and present peptides to the CD8 +
cytotoxic T cells that kill the non-self-peptides from the pathogens. MHC class II
molecules present peptides to the CD4+ T helper cells; these stimulate the B cells
resulting in production of antibodies (Mellman and Steinman, 2001).
Major histocompatibility complex (MHC) class I molecules are becoming
important targets for the virus during immune evasion. Down regulation of MHC class I
expression can attenuate the CD8 T-cell-mediated recognition of infected cells. Herpes
virus family members down regulate the MHC class I presentation by different
mechanisms (Mark et al., 2004). Precisely, HSV-1 produces two proteins that help in
inhibiting antigen attack. The first protein is a viral host shutoff protein that helps in
preventing antigen production by targeting mRNA. The second protein ICP47 acts
directly on the complex called TAP1/2. This complex helps in transport of antigens from
cytosol to the endoplasmic reticulum (ER). Thus, when ICP47 attacks the TAP1/2
complex, then the transportation of antigens to ER will be stopped thereby affecting
further functions (Mark et al., 2004). The transporter associated with antigen processing
(TAP) is essential for peptide delivery from the cytosol into the lumen of the ER. These
peptides are loaded to MHC class I molecules. The loaded MHC class I vacate the ER
5

and present the antigen on the cell surface of cytotoxic T cells (CTLs). Interaction of
cytotoxic T cells leads to the elimination of virus infected cells (Figure 3) (Rupert and
Robert, 2004).
Raftery et al., proposed a mechanism underlying fratricide in active HSV-1
infections. During HSV-1 infection on epithelial cells, free virions can bind to herpes
virus entry mediator (HVEM) molecule and infect the CTLs. These CTLs, when they
recognize the viral antigen will up regulate the CD95L. During this time, HSV-1 blocks
AICD and down regulates MHC class I molecules. This overall mechanism makes CTLs
more susceptible to infection than epithelial cells (Figure 4) (Raftery et al., 1999).

Figure 3: Overview of the MHC I antigen-processing pathway- TAP (Transporter
Associated with antigen Processing), ER (Endoplasmic Reticulum), MHC I (Major
Histocompatibility Complex), BiP (Immunoglobulin Binding Protein), ß2m, ß2microglobulin (Adapted from Rupert and Robert 2004).
6

Figure 4: HSV1-induced fratricide of antiviral CTLs as a mechanism of viral
immune evasion. Antiviral CTLs activated in the draining lymph nodes enter the
epithelial lesions, where they are infected by HSV1 virions 1. Due to inefficient
activity of the TAP (Transporter Associated with antigen Processing) blocker in T
lymphocytes, viral antigens are presented via the MHC class I molecules and
recognized by neighboring CTLs 2. In addition, HSV1 lifts the block for CD95mediated death signals, resulting in fratricide (Adapted from Raftery et al., 1999).

In the current study IFN-γ was used to rescue the murine fibroblast and
keratinocyte cell lines from HSV-1 induced MHC class I down regulation. IFN-γ plays a
major antiviral role during HSV1 infection. It was observed that IFN-γ produced by
CD8+ T cells is effective against HSV-1 infection in adaptive immunity. IFN-γ signaling
7

begins with interaction of IFN-γ with an IFN receptor complex consisting of two
IFNGR1 molecules and two IFNGR2 molecules (Waiboci et al., 2007). The C-terminus
of IFN-γ consists of a nuclear localization sequence (NLS), which plays an important role
in binding of IFN-γ to IFNGRs. Endocytosis of IFN-γ into the cell occurs with an
interaction of IFN-γ NLS domain to IFNGR1. This induces JAK2 auto phosphorylation
on tyrosine residues. Auto phosphorylation of JAK2 induces activation and
phosphorylation of STAT1, then STAT1 delivers a signal to the nucleus. IFNs (type I and
II) select their specific pair of Janus Kinase (JAK), signal transduction and transcription
(STAT) group for translocation of signal to the nucleus (Yokota et al., 2005). In case of
HSV-1 infection, IFN-γ in the trigeminal ganglia plays a key role in controlling the
infection by inhibition of reactivation and inhibition of ICP0 (Minami et al., 2002).
SOCS-1 is an inhibitor of JAK which in turn down regulates IFN-γ expression in
keratinocytes (Frey et al., 2009).
SOCS (Suppressor of Cytokine Signaling) proteins are a family of 8 members;
SOCS-1, SOCS-2, SOCS-3, SOCS-4, SOCS-5, SOCS-6, SOCS-7 and cytokine-inducible
SH2 protein. SOCS has a kinase inhibitory region (KIR) and SRC Homology 2 (SH2)
domains that plays an important role in binding of SOCS-1 to JAK2. When the KIR
region binds to JAK2 tyrosine residue, inhibits the autophosphorylation of STAT1a.
Inhibition of STAT1a autophosphorylation leads to blockage of the IFN-γ signaling
pathway. By the use of SOCS mimetic or Tyrosine kinase inhibitory peptide (Tkip)
during HSV-1 infection, it was observed that peptide mimetic is attached to tyrosine
residue of JAK2. This stops STAT1a phosphorylation during IFN-γ signaling. SOCS-1
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peptide antagonist binds to the KIR region of SOCS-1 that allows JAK2 phosphorylation,
STAT1a phosphorylation and IFN-γ signaling pathway continues (Waiboci et al., 2007).
Viruses have developed successful strategies to overcome the protective effects of
interferons (Peng et al, 2008). HSV-1 infection can induce strong cytokine response in
infected cells such as type I interferons (IFN-α & IFN-β). In keratinocytes HSV-1
infection induces large amounts of IFNs as well as interleukins (IL) 1, 6, and chemokines
(Sprecher et al., 1992). In Human epidermal keratinocytes, INF-γ pretreatment induced
HLA-DR expression and protected the cells from HSV-1 induced MHC class I down
regulation (Mikloska et al., 1996). Antiviral effects of IFN-γ and IFN-γ peptide mimetic
protected fibroblast (L929) cells from HSV-1 induced cytopathic effect, whereas
keratinocyte (HEL-30) cell lines derived from C3H mice were not protected during the
studies. Identical results were observed with cell lines PAM-212 and A2R1. PAM-212
keratinocytes were not protected by IFN-γ during HSV-1 infection and A2R1 fibroblasts
were protected through antiviral effect of the IFN-γ (Frey et al., 2009).
CD8+ T-cells control HSV-1 infection by exocytosis of lytic granules or by
secretion of cytokines IFN-γ and TNF-α (Sheridan et al., 2007). CD8+ T-cells also
control the maintenance of latency and prevent reactivation of HSV-1. In ex-vivo cultures
of latently infected ganglia, IFN-γ and granzyme B secreted by CD8+ T cells inhibited
HSV-1 reactivation by degrading the ICP4 protein (crucial for lytic events) (Knickelbein
et al., 2008). HSV-1 interferes with presentation of antigen on MHC class I molecules
(Lacaille and Androlewicz, 1998), in such situation CTL responses would be insufficient
for viral clearance. Since IFN-γ can up regulate MHC I expression (Mikloska et al.,
1996), this is critical in controlling HSV-1.
9

The hypothesis of this study is HSV-1 infection of murine fibroblasts and
keratinocytes inhibits expression of MHC class I molecules during first 24 hours of
infection. IFN-γ pretreatment of fibroblasts protected them from virus-induced inhibition
of MHC class I expression, but did not protect keratinocytes.
In the current study, fibroblast and keratinocyte cell lines derived from C3H mice
(L929 fibroblasts and HEL-30 keratinocytes) and BALB/c mice (A2R1 fibroblasts and
PAM-212 keratinocytes) responded differently to IFN-γ induction of MHC class I
expression in HSV- 1 infected and IFN-γ pretreated cells. L929 and A2R1 cells expressed
higher levels of MHC class I when treated with IFN-γ than keratinocytes. Different
MOI’s were used to determine the appropriate dilution to use on the cell lines. 0.1 MOI
was chosen because it has cytopathic effects on the cells. Frey et al., observed loss of cell
viability (keratinocytes and fibroblasts) when infected for 48 hours with HSV-1 at 0.1
MOI (Frey et al., 2009). It would be appropriate to observe for the MHC class I
expression up to 24 hours post infection, since the cell viability will be lost by 48 hours
post infection.
The C3H mouse was partially resistant to infection by HSV-1 (Armerding and
Rossiter, 1981). Type I IFN production has been proposed as a mechanism for resistance
(Chmielarczyk et al., 1985). High levels of Type I IFNs were seen in exudates as soon as
2-4 hours after infection (Engler et al., 1982). In contrast, BALB/c mice were not known
to be resistant and they produce low levels of Type I IFNs (Watanabe et al., 1999). These
two mouse cell lines were selected for the current study to identify if the IFN-γ
pretreatment of control cells and infected cells leads to any variation in their resistance
10

pattern. Frey et al., observed that higher concentration of IFN-γ showed more protection
for HSV-1 infection in fibroblast cell lines when compared using lower concentration of
IFN-γ (Frey et al., 2009). Based on their data, a higher concentration of IFN-γ (100
units/ml) has been used in this study.
Immunofluorescence staining was performed for murine fibroblast cell lines
(L929 and A2R1) at 6, 12, and 24 hours intervals post infection with HSV-1, to compare
MHC class I expression. Image J software developed by NIH (National Institute of
Health) was used for analyzing the images of MHC class I stained L929 and A2R1 cells.
Images of the cells stained for actin and MHC class I were merged through Image J
software. Flow cytometry technique was performed for all four cell lines (fibroblasts and
keratinocytes) after 24 hours of infection. The reason for choosing 24 hours post infection
time point was that immunocytochemistry results exhibited high MHC class I expression
for IFN-γ pretreatment, and MHC class I expression was significantly decreased during
HSV-1 infection, when compared to 6 and 12 hours post infection time point. However,
for keratinocytes (HEL-30 (Figure 5), and PAM-212) immunolocalization was not
possible because cells grew in clusters and the staining patterns in individual cells could
not be analyzed by Image J software.

Immunofluorescence staining performed for

keratinocytes HEL-30 (Figure 5) showed an unclear staining pattern. For better results
the immunofluorescence staining for HEL-30 cells was repeated by trypsinizing the cells
to separate them from clumping, resulting in less cell density and decrease in
immunofluorescence intensity due to the loss of cells and disruption of cell membranes
(Figure 6). Hence it was concluded that this method was not appropriate and flow
cytometry technique was selected for identifying MHC class I expression.
11

(a) MHC class I stained

(b) Actin stained

(c) Merged

Figure 5: Images of HEL-30 cells treated with antibodies for (a) MHC class I
(green), (b) actin (red), and (c) MHC class I and actin merged. Bar marker indicate
50 μm size.
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(a) MHC class I stained

(b) Actin stained

(c) Merged

Figure 6: Images of trypsinized HEL-30 cells treated with antibodies for (a) MHC
class I (green), (b) actin (red), and (c) MHC class I and actin merged. Bar marker
indicate 50 μm size.
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MATERIALS AND METHODS
Cell Culture:
L929 cells from C3H mice and A2R1 cells of BALB/C mice are fibroblasts that
populate the dermal layer of the skin. HEL-30 keratinocytes derived from C3H mice, (Dr.
Janice Speshock, Wright Patterson Air Force Base), PAM-212 keratinocytes derived
from BALB/c mice (American Type Culture Collection) and Vero cells (CCL-81, ATCC)
were cultured in Dulbecco’s Modified Eagles Medium (DMEM) (Fisher Scientific,
catalog # SH30243.01) supplemented with 10% heat-inactivated fetal calf serum, and
1μl/ml gentamicin solution. The cells were grown on 100 mm2 tissue culture dishes and
incubated in a humidified incubator at 37o C with 5% CO2.
Virus:
Herpes Simplex Virus-1 strain Syn 17+ (Dr.Nancy Sawtell, Children’s Hospital
Medical Center, Cincinnati, OH) was propagated in the lab. Vero cells were grown in a
75cm² flask and a confluent monolayer was infected with HSV-1 at 0.1 multiplicity of
infection (MOI). Cells were examined and harvested along with medium when cytopathic
effects (cells rounding and detaching from the bottom of the flask) were evident after 3-5
days of infection. Medium was stored as virus stock in 100 μl aliquots at -80⁰C. The
number of plaque forming units (PFU) were calculated after performing a plaque assay
on Vero cells. The virus was dispensed at 0.1 MOI in DMEM containing 2% calf serum
on the cell monolayer in the 24 well culture plates, and then placed in an incubator at 37 o
14

C. The virus was left on the cells for 2 hours and then the culture medium was removed
and replaced with fresh culture medium. Mock infected cells were treated in the same
way, except 2% DMEM was used instead of 10% DMEM. For immunostaining, each cell
line was added to sterile glass coverslips that were placed in 24 well plates and infected
as previously described.
IFN-γ pretreatment and virus infection of cells for immunocytochemistry:
L929 and A2R1 cells were treated with IFN-γ (Peprotech, catalog # 315-05) at
concentration of 100 units/ ml for 24 hours and then infected with HSV-1 at 0.1 MOI. A
list of treated groups and infected groups were detailed in Table 1.

Cell group
treated
Cell only

IFN-γ

HSV-1

_

_

Cell+ virus

_

+

Cell+ IFN-γ

+

_

Cell+ IFN-γ+ virus

+

+

Table 1: List of treated cell groups for current study, specifying which groups are
treated with IFN-γ and infected with HSV-1.

Immunocytochemistry for MHC class I antigen and actin:
At the end of 6, 12, and 24 hours post infection time points, immunocytochemistry
was performed.
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Immunocytochemistry procedure for L929 and HEL-30 cells:
1) The cells were rinsed once with phosphate buffered saline (PBS), at room
temperature (RT) and then the PBS was removed.
2) 4% paraformaldehyde fixative (to preserve cell morphology) was added, and the cells
were incubated at RT for 15 minutes.
3) The paraformaldehyde fixative was removed, and quenched with sodium borohydride
(1mg/ml) that was prepared just prior to use. The cells were incubated in this solution
for 15 minutes at RT.
4) The cells were then washed 3 times with PBS.
5) 3% BSA (Bovine Serum Albumin) blocking solution was added to the cells and
incubated at RT for 30 minutes.
6) The primary biotin conjugated anti mouse MHC I (H-2Kk) (ebiosciences, catalog #
13-5940-82) was prepared in the blocking buffer (diluted 1:100) and then it was
applied to each coverslip.
7) The coverslips were placed in a humidified chamber cell side down, and allowed to
incubate at 4o C overnight.
8) Then coverslips were transferred back to their dishes, and washed three times with
PBS.
9) The secondary FITC conjugated streptavidin (ebiosciences, catalog # 11-4317-87)
prepared in the blocking buffer (diluted 1:100) and Texas red conjugated phalloidin
(Life technologies, catalog # T7471) for actin staining was prepared in the same
blocking buffer (diluted 1:100) were applied to each coverslip, and allowed to
incubate for 2 hours at RT in the dark.
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10) The coverslips were placed back into their dishes, and washed 3 times with PBS.
11) The coverslips were mounted onto glass slides using liquid mounting mediumVectashield (Vector Labs), and sealed with clear nail varnish.

Immunocytochemistry procedure for A2R1 and PAM 212 cells:
1) The cells were rinsed once with phosphate buffered saline (PBS), at room
temperature (RT) and then the PBS was removed.
2) 4% paraformaldehyde fixative was added, and the cells were incubated at RT for 15
minutes.
3) The paraformaldehyde fixative was removed, and quenched with sodium borohydride
(1mg/ml) that was prepared just prior to use. The cells were incubated in this solution
for 15 minutes at RT.
4) The cells were then washed 3 times with PBS.
5) 3% BSA blocking solution was added to the cells which were incubated at RT for 30
minutes.
6) Direct FITC conjugated anti mouse MHC I (H-2Kd/H-2Dd) (ebiosciences, catalog #
11-5998-82) was prepared in the blocking buffer (diluted 1:100) and Texas red
conjugated phalloidin (Life technologies, catalog # T7471) for actin staining was
prepared in the same blocking buffer (diluted 1: 100). Each antibody was applied to
each coverslip, and allowed to incubate for 2 hours at RT in the dark.
7) The coverslips were placed back into their dishes, and washed 3 times with PBS.
8) The coverslips were mounted onto glass slides using liquid mounting mediumVectashield (Vector Labs), and sealed with clear nail varnish.
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Cells were observed under fluorescent microscope (Olympus Epi Fluorescence Spot
Scope with real time color camera) and two images were taken per field. Two different
filters (filter # 4 and 5) were used to capture images for one field, because each secondary
antibody used has a different fluorescent label. Three fields were observed for each group
per experiment, and three experiments were performed at each of the time points
identified.
Image J software by NIH (National Institute of Health) was used to measure MHC
class I fluorescence intensity of L929 and A2R1 immunostained images. The pixel
intensity was measured, and the mean fluorescent intensity was calculated using Image J
software. At least three fields per group, and a minimum of three experiments were
performed. A list of antibodies and isotype controls that were used are detailed in Table
2.
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Antibodies
type

L929 cells

A2R1 cells

HEL 30 cells

PAM 212 cells

Primary
(MHC
class I)

biotin conjugated
anti mouse MHC I
(H-2Kk)
(ebiosciences,
catalog # 13-594082)

FITC
conjugated
anti-mouse
MHC I (H2Kd/H-2Dd)
(ebiosciences,
catalog # 115998-82)

biotin conjugated
anti mouse MHC I
(H-2Kk)
(ebiosciences,
catalog # 13-594082)

FITC
conjugated
anti-mouse
MHC I (H2Kd/H-2Dd)
(ebiosciences,
catalog # 115998-82)

Secondary
(MHC
class I)

FITC conjugated
streptavidin
(ebiosciences,
catalog # 11-431787)

Actin

Texas red
conjugated
phalloidin (Life
technologies,
catalog # T7471)

Isotype
control

FITC conjugated
streptavidin
(ebiosciences,
catalog # 11-431787)

Texas red
conjugated
phalloidin
(Life
technologies,
catalog #
T7471)
FITC
biotin conjugated
conjugated
mouse
mouse IgG2a
IgG1(ebiosciences,
(ebiosciences,
catalog # 13-4714catalog # 1185)
4724-82)

Texas red
conjugated
phalloidin
(Life
technologies,
catalog #
T7471)
FITC
biotin conjugated
conjugated
mouse
mouse IgG2a
IgG1(ebiosciences,
(ebiosciences,
catalog # 13-4714catalog # 1185)
4724-82)
Texas red
conjugated
phalloidin (Life
technologies,
catalog # T7471)

Table 2: List of antibodies and isotype controls used to stain cells for
immunocytochemistry and flow cytometry.

Flow Cytometry:
Cells were harvested for flow cytometry at the 24 hours post infection time point
and cells were detached from the plate with cell stripper solution (Cell grow, catalog #
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25-056-CI). After assessing cell count and viability by trypan blue exclusion, 106 cells
per sample were transferred to 2 ml vial.

Flow cytometry procedure for L929 and HEL-30 cells:
1) To perform surface staining, samples were washed twice with 1% BSA, and blocked
for 1 hour with 3% BSA.
2) L929 and HEL 30 cells were stained with biotin conjugated anti mouse MHC I (H2Kk) (ebiosciences, catalog # 13-5940-82) that was prepared in the blocking buffer
(diluted 1:100) and incubated for 1 hour at 4°C.
3) Samples were washed twice with 1% BSA and stained with FITC conjugated
streptavidin (ebiosciences, catalog # 11-4317-87) that was prepared in the blocking
buffer (diluted 1:100) and incubated for 1 hour at 4°C.
4) After incubation the samples were washed twice with 1% BSA.
5) The final pellet was suspended in 1% sodium azide solution.
Flow cytometry procedure for L929 and A2R1 and PAM-212 cells:
1) L929 and HEL 30 cell samples were washed twice with 1% BSA, and blocked for 1
hour with 3% BSA.
2) Cells were stained with FITC conjugated anti mouse MHC I (H-2Kd/H-2Dd)
(ebiosciences, catalog # 11-5998-82), that was prepared in the blocking buffer
(diluted 1:100) and incubated for 1 hour at 4°C.
3) After incubation the samples were washed twice with 1% BSA.
4) The final pellet was suspended in 1% sodium azide solution.
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For all the samples, flow cytometry was performed using C6 flow cytometer (BD
Accuri), and analyzed with FCS Express 4 plus research edition.

Statistical Analysis:
Using Sigma Plot 12.0, statistical analysis was performed for the Image J
analyzed fluorescence intensity values and mean fluorescence intensity values of flow
cytometry. The values expressed are the Standard Error of the Mean (SEM). The HolmSidak method was used to determine the significance between the treated groups and the
control groups.
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RESULTS
Immunocytochemistry for L929 fibroblast cells:
HSV-1-infected L929 fibroblasts exhibited a decrease in MHC class I
fluorescence intensity at 6 hours post infection (Figure 7) compared with untreated cells.
When these cells were pretreated with IFN-γ, there was an increase in MHC class I
expression in both infected and uninfected cells.
After 12 hours of infection (Figure 8) there was a significant decrease in MHC
class I fluorescence intensity in the virus infected cells, when compared with untreated
cells. When these cells were pretreated, there was an increase in the MHC class I
expression in both infected and uninfected cells. A decrease in cell density was observed
in the HSV-1 infected group.
After 24 hours of infection (Figure 8 & 10c), there was a significant decrease in
MHC class I fluorescence intensity in the virus infected cells when compared with
untreated cells. When these cells were pretreated with IFN-γ, there was an increase in the
MHC class I expression both in infected and uninfected cells. During HSV-1 infection
there was a decrease in the density of cells (Figure 9b & 9d).
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MHC class I stained

Actin stained

Merged

(a)

(b)

(c)

(d)

Figure 7: Immunocytochemistry for L929- 6 hours post infection MHC class I
stained( Green) and actin stained(Red) images: HSV-1 control (a), L929+HSV-1, (b)
L929+ IFN- γ (c), L929+ IFN- γ + HSV-1(d). At 6 hours post infection, no difference
in cell density was observed in between L929 uninfected cells and cells infected with
HSV-1 virus. IFN-γ pretreated cells showed more fluorescent intensity when
compared to cells only. Bar markers indicate 50 μm.
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MHC class I stained

Actin stained

Merged

(a)

(b)

(c)

(d)

Figure 8: Immunocytochemistry for L929- 12 hours post infection MHC class I
stained (Green) and actin stained (Red) images: HSV-1 control (a), L929+HSV-1,
(b) L929+ IFN- γ (c), L929+ IFN- γ + HSV-1 (d). At 12 hours post infection, a
decrease in cell density was observed in infected group when compared with
uninfected group. IFN-γ pretreated and HSV-1 infected cells showed more
fluorescent intensity when compared to infected cells. Bar markers indicate 50 μm.
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MHC class I stained

Actin stained

Merged

(a)

(b)

(c)

(d)

Figure 9: Immunocytochemistry for L929- 24 hours post infection MHC class I
stained( Green) and actin stained(Red) images: HSV-1 control (a), L929+HSV-1, (b)
L929+ IFN- γ (c), L929+ IFN- γ + HSV-1 (d). At 24 hours post infection, a decrease
in cell density was observed in infected group when compared with uninfected
group. IFN-γ pretreated and HSV-1 infected cells showed more fluorescent intensity
when compared to infected cells. Bar markers indicate 50 μm.
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Image J quantification of MHC class I fluorescence intensity for L929 fibroblasts :
When the mean fluorescence was measured and compared, there was a significant
increase in the IFN-γ treated cells when compared with untreated cells (Figure 10).
After 6, 12, and 24 hours of infection (Figure 10), the virus-infected cells showed
a significant decrease in the immunofluorescence intensity, compared to control cells.
After 24 hours of infection (Figure 10c), there was a significant decrease in
immunofluorescence intensity both with virus infected, and uninfected cells. At 24 hours
post infection, the IFN-γ pretreated expressed one fold increase in immunofluorescence
intensity, compared with untreated cells. An increase in MHC class I fluorescence
intensity was observed in IFN-γ pretreated, and HSV-1 infected L929 fibroblast cells,
compared with control cells (Figure 10).
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(a)

(b)

(c)

Figure 10: MHC class I fluorescent Intensity using image J program for L929
fibroblasts at 6, 12, and 24 hours post infection. L929 fibroblasts at 6 hours post
infection (a), L929 fibroblasts at 12 hours post infection (b), L929 fibroblasts at 24
hours post infection (c). At 6, 12 and 24 hours post infection, the MHC class I
fluorescence intensity increased significantly (P<0.001 by ANOVA) in the cells
pretreated with IFN-γ and infected with HSV-1 when compared with the infected
cells.
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Immunocytochemistry for A2R1 fibroblast cells:
HSV-1 infected L929 fibroblasts displayed a decrease in MHC class I
fluorescence intensity at 6 hours post infection (Figure 11) compared with untreated cells.
When these cells were pretreated with IFN-γ there was an increase in MHC class I
expression in both infected and uninfected cell.
After 12 hours of infection (Figure 12), IFN-γ pretreated cells showed an increase
in the MHC class I expression both in infected and uninfected cells.
After 24 hours of infection (Figure 13) there was a significant difference between
the virus infected cells and the untreated cells. When these cells are pretreated with IFNγ, there was an increase in the MHC class I both in infected and uninfected cells. During
HSV-1 infection there was a decrease in the density of cells (Figure 13b & 13d).
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MHC class I stained

Actin stained

Merged

(a)

(b)

(c)

(d)

Figure 11: Immunocytochemistry for A2R1- 6 hours post infection MHC class I
stained( Green) and actin stained(Red) images: HSV-1 control (a), A2R1+HSV-1,
(b) A2R1+ IFN- γ (c), A2R1+ IFN- γ + HSV-1(d). At 6 hours post infection, no
difference in cell density was observed in between A2R1 uninfected cells and cells
infected with HSV-1 virus. IFN-γ pretreated cells showed more fluorescent intensity
when compared with cells only. Bar markers indicate 50 μm.
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MHC class I stained

Actin stained

Merged

(a)

(b)

(c)

(d)

Figure 12: Immunocytochemistry for A2R1- 12 hours post infection MHC class I
stained( Green) and actin stained(Red) images: HSV-1 control (a), A2R1+ HSV-1,
(b) A2R1+ IFN-γ (c), A2R1+ IFN- γ + HSV-1(d). At 12 hours post infection, a
decrease in cell density was observed in infected group when compared to
uninfected group. IFN-γ pretreated and HSV-1 infected cells showed more
fluorescent intensity when compared with infected cells. Bar markers indicate 50
μm.
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MHC class I stained

Actin stained

Merged

(a)

(b)

(c)

(d)

Figure 13: Immunocytochemistry for A2R1- 24 hours post infection MHC class I
stained( Green) and actin stained(Red) images: HSV-1 control (a), A2R1+ HSV-1,
(b) A2R1+ IFN- γ (c), A2R1+ IFN- γ + HSV-1(d). At 24 hours post infection, a
decrease in cell density was observed in infected group when compared to
uninfected group. IFN-γ pretreated and HSV-1 infected cells showed more
fluorescent intensity when compared with infected cells. Bar markers indicate 50
μm.

31

Image J quantification of MHC class I fluorescence intensity for A2R1 fibroblasts :
When the mean fluorescence was measured and compared, there was a significant
increase in the IFN-γ treated A2R1 cells compared with untreated cells (figure 14).
After 24 hours of infection (figure 14c), there was a significant decrease in the
virus infected and uninfected cells. At 24 hours post infection, the IFN-γ pretreated cells
expressed 2 fold increase in immunofluorescence, compared with untreated cells. HSV-1
infected cells with IFN-γ pretreatment exhibited an increase in MHC class I fluorescence
intensity, compared to the control cells.
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(a)

(b)

(c)

Figure 14: MHC class I fluorescent Intensity using image J program for A2R1
fibroblasts at 6, 12, and 24 hours post infection. A2R1 fibroblasts at 6 hours post
infection (a), A2R1 fibroblasts at 12 hours post infection (b), A2R1 fibroblasts at 24
hours post infection (c). At 6, 12 and 24 hours post infection, a significant increase in
the MHC class I fluorescence intensity was observed (P<0.001 by ANOVA) in the
cells pretreated with IFN-γ and infected with HSV-1 when compared with infected
cells.
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Comparision of MHC class I fluorescence Intensity for fibroblasts at 6,12 and 24
hours post infection:
For both fibroblast cell lines L929 (Figure 15) and A2R1 (Figure 16), at 6, 12, and
24 hours post infection, a significant increase in the MHC class I fluorescence intensity
was observed (P<0.001 by ANOVA) in the cells pretreated with IFN-γ and infected with
HSV-1, compared with infected cells.
L929

Figure 15: Comparision of MHC class I fluorescent Intensity using image J program
for L929 fibroblasts at 6. 12 and 24 hours post infection time points. At 6, 12 and 24
hours post infection, a significant increase in the MHC class I fluorescence intensity
was observed (P<0.001 by ANOVA) in the cells pretreated with IFN-γ and infected
with HSV-1 when compared to infected cells.
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A2R1

Figure 16: Comparision of MHC class I fluorescent Intensity using image J program
for A2R1 fibroblasts at 6. 12 and 24 hours post infection time points. At 6, 12 and 24
hours post infection, a significant increase in the MHC class I fluorescence intensity
was observed (P<0.001 by ANOVA) in the cells pretreated with IFN-γ and infected
with HSV-1 when compared to infected cells.

MHC class I immunofluorescence intensity by flow cytometry:
Flow cytometry was performed for all four cell lines, fibroblasts (A2R1 and
L929) and keratinocytes (PAM-212 & HEL-30) at 24 hours post infection time point.
Initially three experiments for each cell line were performed, taking the samples from
same cell culture plate, and later three individual experiments were performed taking the
samples from three different cell culture plates.
For all the Flow cytometry graphs, isotype control (purple shaded) was included
in the graph. Furthermore, statistical analysis for mean fluorescence values of the MHC
class I was perfomed through One-way Anova using Sigma plot 12.0. All the groups
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passed normality test and equal variance test. Significant differences were observed
between all treated groups of fibroblasts and keratinocytes and the p value was <0.001.
MHC class I immunofluorescence intensity by flow cytometry for L929 fibroblasts :
After 24 hours post infection in treated L929 fibroblasts, there was an increase in the
MHC class I mean fluorescence intensity in IFN-γ pretreated cells. Cells pretreated with
IFN-γ showed 4.5 fold increase in mean fluorescence compared with untreated cells
(Figure 17 & 18). The HSV-1 infected cells were rescued from the infection upon IFN-γ
pretreatment.

36

(a)

(b)

(c)

Figure 17: Major histocompatibility complex class I antigen expression for L929
fibroblasts through flow cytometry. Fluorescence-activated cell sorting analysis of
HSV-1-infected cells (red) compared with uninfected cells (black) (a), IFN-γ
pretreated and HSV-l-infected cells (blue) compared with IFN- γ pretreated and
uninfected (orange) (b). IFN-γ–pretreated (orange) compared with untreated cells
(black) (c). Isotype control (purple filled) was included in all groups but with no
change in fluorescence. At 24 hours post infection, an increase in the MHC class I
fluorescence intensity was observed in the cells pretreated with IFN-γ and infected
with HSV-1 when compared with infected cells. Each histogram represents data for
106 cells. X axis = log fluorescence intensity, Y axis = number of events.
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Statistical analysis was performed for mean fluorescence values of MHC class I
fluorescence intensity using One-way Anova analysis using Sigma plot 12.0. There was a
statistically significant difference between all treated groups for L929 fibroblasts. The p
value is <0.001 (Figure 18).

Figure 18: L929 fibroblasts- Graph for flow cytometry mean fluorescent values at
24 hours post infection. Each bar represents average of three values. Values are
taken from three different experiments. At 24 hours post infection, a significant
increase in the MHC class I fluorescence intensity was observed (P<0.001 by
ANOVA) in the cells pretreated with IFN-γ and infected with HSV-1 when
compared to infected cells.

MHC class I immunofluorescence intensity by flow cytometry for A2R1 fibroblasts:
After 24 hours post infection, a significant increase in the MHC class I mean
fluorescence intensity was observed in IFN-γ pretreated cells compared to untreated cells.
IFN-γ pretreatment led to a 3 fold increase in mean fluorescence compared with untreated
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cells (Figure 19 & 20). The HSV-1 infected cells were rescued from the infection upon
IFN-γ pretreatment.

(a)

(b)

(c)

Figure 19: Major histocompatibility complex class I antigen expression for A2R1
fibroblats through flow cytometry. Fluorescence-activated cell sorting analysis of
HSV-1-infected cells (red) compared with uninfected cells(black) (a), IFN-γ
pretreated and HSV-l-infected cells (blue) compared with IFN-γ pretreated and
uninfected (orange) (b). IFN-γ–pretreated (orange) compared with untreated cells
(black) (c). Isotype control (purple filled) was included in all groups but with no
change in fluorescence. At 24 hours post infection, an increase in the MHC class I
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fluorescence intensity was observed in the cells pretreated with IFN-γ and infected
with HSV-1 when compared with infected cells. Each histogram represents data for
106 cells. X axis = log fluorescence intensity, Y axis = number of events.

Statistical analysis was performed for mean fluorescent values of MHC class I
fluorescence intensity using One-way Anova analysis using Sigma plot 12.0. There was a
statistically significant difference between all treated groups for A2R1 fibroblasts. The p
value was <0.001 (Figure 20).

Figure 20: A2R1 fibroblasts- Graph for flow cytometry mean fluorescent values at
24 hours post infection. Each bar represents average of three values. Values are
taken from three different experiments. At 24 hours post infection, a significant
increase in the MHC class I fluorescence intensity was observed (P<0.001 by
ANOVA) in the cells pretreated with IFN-γ and infected with HSV-1 when
compared to infected cells.
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MHC class I immunofluorescence intensity by flow cytometry for PAM-212
keratinocytes :
After 24 hours post infection in PAM-212 keratinocytes, IFN-γ pretreated cells
expressed 1 fold increase in mean fluorescence compared with untreated cells. The HSV1 infected cells expressed relatively less intensity than the cell only. IFN-γ pretreated and
HSV-1 infected cells showed a slight raise in intensity but not up to the basal level like
untreated cells, and the cells were not rescued from the infection (Figure 21 & 22).
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(a)

(b)

(c)

Figure 21: Major histocompatibility complex class I antigen expression for PAM212 keratinocytes through flow cytometry. Fluorescence-activated cell sorting
analysis of HSV-1-infected cells (red) compared with uninfected cells (black) (a),
IFN-γ pretreated and HSV-l-infected cells (blue) compared with IFN-γ pretreated
and uninfected (orange) (b). IFN-γ– pretreated (orange) compared with untreated
cells (black) (c). Isotype control (purple filled) was included in all groups but with
no change in fluorescence. At 24 hours post infection, a significant increase in the
MHC class I fluorescence intensity was observed in the cells pretreated with IFN-γ
when compared with control cells. Each histogram represents data for 10 6 cells. X
axis = log fluorescence intensity, Y axis = number of events.
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Statistical analysis was performed for mean fluorescence values of MHC class I
fluorescence intensity using One- way Anova analysis on Sigma plot 12.0. There was a
statistically significant difference between all treated groups for PAM-212 keratinocytes.
p value was <0.001 (Figure 22).

Figure 22: PAM-212 keratinocytes- Graph for flow cytometry mean fluorescent
values at 24 hours post infection. Each bar represents average of three values.
Values are taken from three different experiments. At 24 hours post infection, a
significant increase in the MHC class I fluorescence intensity was observed
(P<0.001 by ANOVA) in the cells pretreated with IFN-γ when compared to control
cells.

MHC class I intensity by Flow cytometry for HEL-30 keratinocytes :
After 24 hourss of infection in HEL-30 keratinocytes, IFN-γ pretreated cells
expressed one fold increase in mean fluorescence compared to the untreated cells; this
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was similar to the results obtained for other keratinocyte PAM-212. IFN-γ pretreated and
HSV-1 infected cells expressed an increase in fluorescence intensity compared with
HSV-1 infected cells, but this increase was not up to the basal level of untreated cells and
the cells were not protected from the infection. Both keratinocytes expressed similar
pattern of MHC class I expression for the test groups but HEL-30 cells showed more
susceptibility to HSV-1 infection (Figure 23 & 24).
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(a)

(b)

(c)

Figure 23: Major histocompatibility complex class I antigen expression for HEL-30
keratinocytes through flow cytometry. Fluorescence-activated cell sorting analysis
of HSV-1-infected cells (red) compared with uninfected cells (black) (a), IFN-γ
pretreated and HSV-l-infected cells (blue) compared with IFN-γ pretreated and
uninfected (orange) (b). IFN-γ– pretreated (orange) compared with untreated cells
(black) (c). Isotype control (purple filled) was included in all groups but with no
change in fluorescence. At 24 hours post infection, a significant increase in the MHC
class I fluorescence intensity was observed in the cells pretreated with IFN-γ when
compared to control cells. Each histogram represents data for 10 6 cells. X axis = log
fluorescence intensity, Y axis = number of events.
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Statistical analysis was performed for mean fluorescence values of the MHC class
I fluorescence intensity using One- way Anova analysis on Sigma plot 12.0. There was a
statistically significant difference between all treated groups for HEL-30 keratinocytes. p
value was <0.001(Figure 24).

Figure 24: HEL-30 keratinocytes- Graph for flow cytometry mean fluorescent
values at 24 hours post infection. Each bar represents average of three values.
Values are taken from three different experiments. At 24 hours post infection, a
significant increase in the MHC class I fluorescence intensity was observed (P<0.001
by ANOVA) in the cells pretreated with IFN-γ when compared to control cells.
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The flow cytometry data for the fibroblasts and keratinocytes was summarized in
Table 3. In this table, treated and infected groups were compared with contorl group and
indicated the variations in MHC class I fluorescence intensity.

A2R1

L929

PAM-212

HEL-30

Cell+ virus

Decreased

Decreased

Decreased

Decreased

Cell+ IFN-γ

Increased

Increased

Increased

Increased

Cell+ IFN-γ + virus

Increased

Increased

Decreased

Decreased

Table 3: Flow cytometry results summary for Fibroblasts (L929 & A2R1) and
Keratinocytes (HEL-30 & PAM-212) compared with only cells (control) at 24 hours
post infection.
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DISCUSSION
In the current study, a difference was observed in the viral effects of IFN-γ on
fibroblast (L929) compared to keratinocyte (HEL-30) cell lines derived from C3H mice.
L929 fibroblasts were rescued from HSV-1 induced down regulation of MHC class I
(Figure 17 & 18) while the HEL-30 keratinocytes were not protected (Figure 23 & 24).
The induction of MHC class I by IFN-γ following HSV-1 infection of another murine
keratinocyte cell line derived from BALB/c mice (PAM-212), was similar to that seen in
HEL-30 cells (Figure 21 & 22). Similar to L929 cells, a fibroblast cell line from BALB/c
mice (A2R1) was protected from HSV-1 induced down regulation of MHC class I
(Figure 19 & 20).
Keratinocytes activated by IFN-γ pretreatment exhibited MHC class I, MHC class
II and ICAM-1 expression (Mikloska et al., 1996; Mikloska and Cunningham, 1998).
These factors are important for cell survival during infection. If IFN-γ action is inhibited,
virus can readily infect the cells. Frey et al.,(2009) observed that IFN-γ pretreatment
permitted survival of fibroblasts when infected with HSV-1 at 0.1 MOI. Fibroblasts and
keratinocytes lost viability by 48 hours after infection with 0.1 MOI of HSV-1. Frey also
observed an increase in expression of SOCS-1, which is a negative regulator of IFN-γ,
during HSV-1 infection in keratinocytes (Frey et al., 2009). In the current study, HSV-1
infected keratinocytes alone expressed significantly less MHC class I, compared with
untreated cells by 24 hours post infection (Figure 21, 22, 23 & 24). Down
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regulation of MHC class I expression during virus infection probably results from cell
death during infection. To account for this, a cell viability count should be performed
before analyzing the samples in flow cytometry. In the current study, virus infected cells
(Figure 7(b), 9(b)) expressed less MHC class I seen in immunofluorescence stained
images compared with cell only (Figure 7(a), 9(a)). There was a decrease in MHC class I
expression in virus infected cells.
In this study, Immunofluorescent staining for expression of MHC class I
molecules in IFN- treated and HSV-1 infected cells was performed using two methods,
namely, immunocytochemistry and flow cytometry. Only the fibroblast cell lines could
be examined by both methods. To analyze immunofluorescence intensity of
immunocytochemistry images, Image J software was used.
In fact of the methods, at 24 hour post infection of L929 cells, the IFN-γ treated
cells increased expression of MHC class I. A 4.5 fold increase in fluorescence intensity
was observed with flow cytometry (Figure 17 & 18), whereas 1.5 fold increase was seen
with Image J software quantification of immunofluorescence, compared to untreated cells
(Figure 10(c)).
A similar pattern resulted with A2R1 fibroblasts at 24 hours post infection. The
IFN-γ treated cells showed 3 fold increase in fluorescence intensity by flow cytometry
(Figure 19 & 20), whereas a 1.5 fold increase was seen with Image J software
quantification of immunofluorescence, compared with untreated cells (Figure 14(c)).
Similar patterns of MHC class I expression was observed using both Image J and flow
cytometry quantifications, validating the use of Image J analysis of fluorescence intensity
for such studies.
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Currently, various laboratories are using Image J as the standard software for
quantification of MHC class I immunofluorescence. For example, surface MHC class I
levels were quantified during coxsackie virus B3 (CVB3) infection using Image J
software (Christopher et al., 2007).
In conclusion, the current results support the data presented by Frey et al., (2009).
Fibroblasts are protected against HSV-1 infection by treating the cells with IFN-γ, and
keratinocytes are refractory to IFN-γ treatment. The MHC I expression can be
successfully up regulated in normal and infected cells of L929 (Figure 17 & 18) and
A2R1 fibroblasts (Figure 19 & 20)). IFN-γ can also up regulate MHC class I expression
in keratinocytes (PAM-212 (Figure 21 & 22) and HEL-30 (Figure 23 & 24)), but during
HSV-1 infection, the SOCS-1 levels increased in keratinocytes (Frey et al., 2009), which
can interrupt the IFN-γ signaling pathway.
The current results indicate that fibroblasts respond well to IFN-γ treatment, since
the fibroblast cells (L929 & A2R1) expressed an average of 3.5 fold increase in MHC
class I expression when treated with IFN-γ, whereas keratinocytes expressed a 1-fold
increase. The possible reasons can be the expression of higher levels of endogenous
SOCS-1 in keratinocytes when compared with fibroblast cells (Frey et al., 2009). Frey et
al. (2009) also observed that IFN-γ itself up regulates SOCS-1 expression in
keratinocytes. In his study SOCS inhibitors were used in order to increase the cell
survival in IFN-γ treated and HSV-1 infected keratinocytes (Frey et al., 2009).
In future studies, use of SOCS-1 inhibitors along with IFN-γ treatments for
keratinocytes would be appropriate to increase the MHC class I expression during HSV-1
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infection. Identification of the mRNA levels of the MHC class I protein through the RTPCR technique would validate the results.
HSV-1 evades immune system through SOCS-1 by blocking the JAK/STAT
pathway; this is an efficient way to suppress the host defense reaction (Miller et al.,
1998). HEL-30 keratinocytes and PAM-212 keratinocytes express higher levels of
endogenous SOCS-1 than fibroblast cells (Frey et al., 2009). A similar mechanism was
observed by Yokota et al. (2004) during studies with SOCS-3 and demonstrated that IFNα signal transduction pathway was blocked in JAK phosphorylation site in the same way
as SOCS-1. Western blot revealed that STAT1 phosphorylation was inhibited in SOCS-3
over expressed FL cells. These results showed that HSV-1 also stimulates SOCS-3
expression as its anti-viral function (Yokota et al., 2004).
Although SOCS proteins play an important role in inhibition of host anti-viral
defense mechanisms, it is not the only strategy stimulated by HSV-1. Lin et al. (2004)
demonstrated that other strategies which do not depend on IFN-γ, can be used by HSV-1
to defeat host antiviral defense. They observed that the HSV-1 immediate early proteinICP0 and virus shut off protein together act against immune response. Therefore, further
research is required to verify which of these strategies are more effective to block host
immune response by HSV-1. This could be considered as one limitation on this approach
and would be an appropriate subject for future studies.
In addition, HSV-1 blocks the signaling effects of type 1 interferons by reducing
the effects of the double-stranded RNA-activated protein kinase (PKR) (Melroe et al.,
2004). Frey et al. (2009) mentioned that treatment of cells with IFN-β and IFN-γ inhibits
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viral replication and mRNA accumulation to a greater extent than treatment with either
IFN alone. IFN-γ can also be used in combination of type 1 interferons.
For future studies, it would be of interest to verify whether the combinations of
interferons exert changes in SOCS-1 levels through Western blot technique, assessing
mRNA levels using RT-PCR, while simultaneously measuring MHC class I expression
levels.
Frey et al. (2009) observed that keratinocytes (HEL-30) were refractory to IFN-γ
induction of an antiviral state during HSV-1 infection. Refractiveness of keratinocytes to
IFN-γ was attributed to the production of SOCS-1. Both IFN-γ and HSV-1 were found to
up regulate production of SOCS-1 in keratinocytes. Identifying whether SOCS-1
inhibitors would permit the keratinocytes to express any type I interferon response and
protect the cells from HSV-1 induced MHC class I down regulation would be analyzed.
Recent studies have demonstrated that keratinocytes are capable of producing proinflammatory cytokines in response to virus infection (Hukkanen et al., 2002). Production
of IL-1β, TNF-α and IL-6 was observed during HSV-1 infection of primary keratinocytes
from BALB/C and C57Bl/6 mice (Sprecher and Becker, 1992). Fibroblasts also have
immune functions. Particularly, fibroblasts secrete pro-inflammatory cytokines that
mediate extravasation of leukocytes (McGettrick et al., 2009). Determination of these
secretory cytokines prior and post virus infection would give further insight on
inflammatory response following virus infection and the influence of these cytokines on
the MHC class I expression levels. A brief experimental design is proposed for measuring
type 1 interferons during HSV-1 infection in few steps:
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1. Infected cells could be lysed, and IFN-β levels measured using a murine IFN-β
ELISA kit (Ahmed et al., 2010). IFN-α can be measured using IFN-α ELISA kit
(Fujisawa et al., 1997). Using cell lysates for measuring IFN levels would show the
IFN response to early infection. Culture supernatant fluids of fibroblast and
keratinocyte cells can also be analyzed for IFN-β, and IFN-α production (Fujisawa et
al., 1997).
2. Measuring the IFN levels before infection would show the actual amounts produced
post infection.
3. Fluorescently labeled anti mouse IFN antibodies can be used if the ELISA kits are not
sensitive enough to detect interferons.
4. Western blot technique can be used to measure protein levels (interferon levels).
5. Further validations can be done by detecting mRNA levels for these interferons
through RT PCR.
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